Advertisement

Topics

European Society for Medical Oncology (ESMO) - Osimertinib Improves Symptoms in Advanced Lung Cancer Patients

14:27 EDT 4 May 2017 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
GENEVA, May 5, 2017 /PRNewswire/ -- Osimertinib improves cancer-related symptoms in patients with advanced lung cancer, according to an analysis of patient-reported outcomes from the AURA3 phase III clinical trial presented today at the European Lung C...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "European Society for Medical Oncology (ESMO) - Osimertinib Improves Symptoms in Advanced Lung Cancer Patients"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...